查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1427970

2024 年 POC 血糖檢測全球市場報告

Point-of-Care Glucose Testing Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

POC血糖檢測市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 5.3% 的複合年成長率 (CAGR) 成長至 59.9 億美元。預測期內的成長被認為是由於遠端醫療醫療服務的擴展、糖尿病照護中個人化醫療的日益重視、糖尿病管理計劃的廣泛普及、對葡萄糖檢測相關研發的投資增加以及連續檢測的引入。預測期內的主要趨勢包括穿戴式血糖監測設備的開發、血糖測試中智慧型手機連接的整合、家庭醫療保健環境中就地檢驗的普及、血糖資料分析中人工智慧的引入，以及預計遠端監控將會擴大。

由於糖尿病盛行率不斷上升，POC 血糖檢測市場預計將成長。糖尿病是一種導致血糖值升高的慢性代謝疾病，隨著時間的推移，會對各種器官造成重大風險。 POC 血糖檢測是一種廣泛使用的技術，可幫助測量住院患者的血糖值，並有助於根據血糖變化做出快速治療方法決策。特別是，這項技術可以提高治療效果並改善糖尿病管理。根據美國疾病管制與預防中心（CDC）2022年的統計數據，2021年美國約有3,730萬人患有糖尿病，佔人口的11.3%。此外，國際糖尿病聯盟於2021年11月宣布，全球糖尿病人口將從2030年的6.43億人（11.3%）增加到2045年的7.83億人（12.2%）。該報告強調了糖尿病對POC的重大影響血糖檢測市場。

人口老化的加劇進一步加速了POC血糖檢測市場的成長。隨著人口轉向老化，老年人口比例增加，POC血糖檢測變得越來越重要。這項技術對於老年人，特別是那些糖尿病高風險族群或已經被診斷出患有糖尿病的人來說，具有重要意義。世界衛生組織預測，到 2030 年，全球六分之一的人將超過 60 歲。 60歲及以上人口比例預計將從2020年的10億增加到14億，到2050年，全球60歲及以上人口預計將加倍，達到21億。因此，人口老化的加劇是POC血糖檢測市場的關鍵驅動力。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球POC血糖檢測市場，依產品、效能及預測細分，2018-2023、2023-2028、2033
  • 刺血針和採血裝置
  • 條
  • 儀表
  • 全球POC血糖測試市場，依測試地點細分，實際與預測，2018-2023年、2023-2028年、2033年
  • 指尖
  • 替代站點測試
  • 全球POC血糖檢測市場，依應用細分、實際及預測，2018-2023年、2023-2028年、2033年
  • 1型糖尿病
  • 2型糖尿病
  • 全球POC血糖測試市場，按最終用戶細分，實際和預測，2018-2023年、2023-2028年、2033年
  • 專業診斷中心
  • 醫院和診所
  • 居家照護環境
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球POC血糖檢測市場，按地區、績效及預測，2018-2023年、2023-2028年、2033年
  • 全球POC血糖檢測市場，依國家、實際及預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • POC血糖檢測市場競爭形勢
  • POC血糖檢測市場公司概況
    • F Hoffmann-La Roche Ltd.
    • Abbott Laboratories Inc.
    • Danaher Corporation
    • Siemens Healthineers
    • Becton, Dickinson and Company

第31章 其他大型創新公司

  • TaiDoc Technology Corporation
  • B. Braun Melsungen AG
  • Beckman Coulter Inc.
  • Nipro Corporation
  • Dexcom Inc.
  • Bio-Rad Laboratories Inc.
  • LifeScan Inc.
  • Nova Biomedical Corporation
  • Ypsomed AG
  • Ascensia Diabetes Care Holdings AG
  • Trividia Health Inc.
  • Radiometer Medical ApS
  • HemoCue AB
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r13814

Point-of-care glucose testing denotes a quality-assured pathology service administered in close proximity to the patient rather than within the conventional confines of a clinical laboratory. Clinicians or individuals employ small handheld units or glucose analyzers, along with testing strips, for glucose testing on whole blood. This approach reduces the duration from specimen collection to result verification, leading to swifter therapeutic intervention, diminished preanalytical errors, and enhanced patient care.

The primary components in point-of-care glucose testing encompass lancet and lancing devices, strips, and meters. Lancets, small sharp instruments, puncture the skin to extract a small blood drop for testing, while lancing devices securely hold the lancet and are activated with a simple button push. These devices facilitate straightforward blood withdrawal and assessment of blood glucose levels using a blood glucose monitor and test strips in point-of-care glucose testing. Testing sites include fingertips and alternate site testing, applied in both type-1 and type-2 diabetes. Various end-users, such as professional diagnostic centers, hospitals and clinics, home care settings, among others, utilize these methods.

The point-of-care glucose testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care glucose testing market statistics, including point-of-care glucose testing industry global market size, regional shares, competitors with a point-of-care glucose testing market share, detailed point-of-care glucose testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care glucose testing industry. This point-of-care glucose testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care glucose testing market size has grown strongly in recent years. It will grow from $4.63 billion in 2023 to $4.88 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth observed in the historical period can be credited to the increasing prevalence of diabetes, heightened awareness of diabetes management, the expansion of the aging population, the augmentation of healthcare infrastructure, and the adoption of point-of-care testing.

The point-of-care glucose testing market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be ascribed to the expansion of telemedicine services, an increasing emphasis on personalized medicine in diabetes care, the proliferation of diabetes management programs, heightened investment in research and development related to glucose testing, and the adoption of continuous glucose monitoring. Key trends expected in the forecast period encompass the development of wearable glucose monitoring devices, the integration of smartphone connectivity in glucose testing, the proliferation of point-of-care testing in home healthcare settings, the adoption of artificial intelligence in glucose data analysis, and the expansion of remote patient monitoring for diabetes.

The point-of-care glucose testing market is anticipated to experience growth, driven by the increasing prevalence of diabetes. Diabetes, a chronic metabolic disorder elevating blood glucose levels, poses severe risks to various organs over time. Point-of-care glucose testing, a widely used technology, aids in determining glucose levels in hospitalized patients, facilitating prompt treatment decisions in response to glycemic changes. Notably, this technology enhances therapeutic outcomes and improves diabetes management. Statistics from 2022 by the Centers for Disease Control and Prevention (CDC) revealed that around 37.3 million people had diabetes in the United States in 2021, constituting 11.3% of the population. Additionally, projections from the International Diabetes Federation in November 2021 forecasted a global diabetic population increase from 643 million (11.3%) in 2030 to 783 million (12.2%) by 2045, underscoring the significant impact of diabetes on the point-of-care glucose testing market.

The growth of the point-of-care glucose testing market is further fueled by the rising aging population. As demographics shift toward an aging population, characterized by an increasing proportion of elderly individuals, point-of-care glucose testing becomes increasingly crucial. This technology serves essential purposes for older individuals, particularly those at higher risk of diabetes or already diagnosed. The World Health Organization projected that by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion, and by 2050, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion. Therefore, the growing aging population is a significant driver of the point-of-care glucose testing market.

Product innovation is a key trend gaining traction in the point-of-care glucose testing market, with major companies focused on developing innovative products. For instance, F. Hoffmann-La Roche AG introduced Cobas Pulse in January 2022, a new point-of-care blood glucose monitor designed for healthcare staff. This handheld device includes an automated glucose test strip reader, camera, and touchscreen, housed in a rugged casing that can be disinfected and used across all age groups, including newborns and intensive care patients. The innovation aims to enhance physicians' workflow by integrating Glucommander dosage software and offering downloadable decision-support apps.

Major companies in the point-of-care glucose testing market are also directing their efforts towards developing advanced solutions such as glucose-ketone monitoring sensors. Abbott Laboratories announced in June 2022 the development of a first-of-its-kind biowearable sensor system that continuously monitors glucose and ketones in diabetic patients. This breakthrough device, granted FDA designation, represents a significant advancement in regulatory status and is set to become the most compact and slender monitoring device globally. It integrates seamlessly with Abbott's digital ecosystem, allowing remote monitoring by healthcare professionals.

In November 2021, Johnson & Johnson acquired Inverness Medical Technology for $1.3 billion, aiming to strengthen its product portfolio in glucose testing. Inverness Medical Technology, a medical device company, brought valuable resources and a robust pipeline of blood glucose meters and test strips to enhance Johnson & Johnson's competitive position in the point-of-care glucose testing market.

Major companies operating in the point-of-care glucose testing market report are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings PLC, Trinity Biotech PLC, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Bluedrop Medical Limited

North America was the largest region in the point of care glucose testing market in 2023. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care glucose testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care glucose testing market consists of revenues earned by entities by providing services such as diagnosis, monitoring, screening, and testing regimes to offer enhanced therapeutic intervention and patient care in lesser time. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care glucose testing market also includes sales of rapid assay dipsticks, glucose monitoring kits, and multifunctional benchtop devices which are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care Glucose Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care glucose testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care glucose testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care glucose testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Lancet And Lancing Devices; Strips; Meters
  • 2) By Testing Site: Fingertips; Alternate Site Testing
  • 3) By Applications: Type-1 Diabetes; Type-2 Diabetes
  • 4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Danaher Corporation; Siemens Healthineers; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care Glucose Testing Market Characteristics

3. Point-of-Care Glucose Testing Market Trends And Strategies

4. Point-of-Care Glucose Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Point-of-Care Glucose Testing Market Size and Growth

  • 5.1. Global Point-of-Care Glucose Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Point-of-Care Glucose Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Point-of-Care Glucose Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Point-of-Care Glucose Testing Market Segmentation

  • 6.1. Global Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lancet And Lancing Devices
  • Strips
  • Meters
  • 6.2. Global Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fingertips
  • Alternate Site Testing
  • 6.3. Global Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Type-1 Diabetes
  • Type-2 Diabetes
  • 6.4. Global Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Professional Diagnostic Centers
  • Hospitals And Clinics
  • Home Care Settings
  • Other End Users

7. Point-of-Care Glucose Testing Market Regional And Country Analysis

  • 7.1. Global Point-of-Care Glucose Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Point-of-Care Glucose Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Point-of-Care Glucose Testing Market

  • 8.1. Asia-Pacific Point-of-Care Glucose Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Point-of-Care Glucose Testing Market

  • 9.1. China Point-of-Care Glucose Testing Market Overview
  • 9.2. China Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Point-of-Care Glucose Testing Market

  • 10.1. India Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Point-of-Care Glucose Testing Market

  • 11.1. Japan Point-of-Care Glucose Testing Market Overview
  • 11.2. Japan Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Point-of-Care Glucose Testing Market

  • 12.1. Australia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Point-of-Care Glucose Testing Market

  • 13.1. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Point-of-Care Glucose Testing Market

  • 14.1. South Korea Point-of-Care Glucose Testing Market Overview
  • 14.2. South Korea Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Point-of-Care Glucose Testing Market

  • 15.1. Western Europe Point-of-Care Glucose Testing Market Overview
  • 15.2. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Point-of-Care Glucose Testing Market

  • 16.1. UK Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Point-of-Care Glucose Testing Market

  • 17.1. Germany Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Point-of-Care Glucose Testing Market

  • 18.1. France Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Point-of-Care Glucose Testing Market

  • 19.1. Italy Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Point-of-Care Glucose Testing Market

  • 20.1. Spain Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Point-of-Care Glucose Testing Market

  • 21.1. Eastern Europe Point-of-Care Glucose Testing Market Overview
  • 21.2. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Point-of-Care Glucose Testing Market

  • 22.1. Russia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Point-of-Care Glucose Testing Market

  • 23.1. North America Point-of-Care Glucose Testing Market Overview
  • 23.2. North America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Point-of-Care Glucose Testing Market

  • 24.1. USA Point-of-Care Glucose Testing Market Overview
  • 24.2. USA Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Point-of-Care Glucose Testing Market

  • 25.1. Canada Point-of-Care Glucose Testing Market Overview
  • 25.2. Canada Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Point-of-Care Glucose Testing Market

  • 26.1. South America Point-of-Care Glucose Testing Market Overview
  • 26.2. South America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Point-of-Care Glucose Testing Market

  • 27.1. Brazil Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Point-of-Care Glucose Testing Market

  • 28.1. Middle East Point-of-Care Glucose Testing Market Overview
  • 28.2. Middle East Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Point-of-Care Glucose Testing Market

  • 29.1. Africa Point-of-Care Glucose Testing Market Overview
  • 29.2. Africa Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Point-of-Care Glucose Testing Market Competitive Landscape And Company Profiles

  • 30.1. Point-of-Care Glucose Testing Market Competitive Landscape
  • 30.2. Point-of-Care Glucose Testing Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton, Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Point-of-Care Glucose Testing Market Other Major And Innovative Companies

  • 31.1. TaiDoc Technology Corporation
  • 31.2. B. Braun Melsungen AG
  • 31.3. Beckman Coulter Inc.
  • 31.4. Nipro Corporation
  • 31.5. Dexcom Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. LifeScan Inc.
  • 31.8. Nova Biomedical Corporation
  • 31.9. Ypsomed AG
  • 31.10. Ascensia Diabetes Care Holdings AG
  • 31.11. Trividia Health Inc.
  • 31.12. Radiometer Medical ApS
  • 31.13. HemoCue AB
  • 31.14. EKF Diagnostics Holdings plc
  • 31.15. Trinity Biotech plc

32. Global Point-of-Care Glucose Testing Market Competitive Benchmarking

33. Global Point-of-Care Glucose Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Point-of-Care Glucose Testing Market

35. Point-of-Care Glucose Testing Market Future Outlook and Potential Analysis

  • 35.1 Point-of-Care Glucose Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Point-of-Care Glucose Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Point-of-Care Glucose Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer